Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05752448

POSTCARE-O: SURVIVORSHIP CARE FOR WOMEN LIVING WITH OVARIAN CANCER

Conditions: Ovary Cancer, Stage II-IV, Quality of Life, Depressive Symptoms

Sex: Female
Ages: 18 Years – N/A
Phase: PHASE3
Enrollment: 120
Sponsor: Baylor College of Medicine

Summary

This study will enroll 120 women living with ovarian cancer following completion of initial treatment. Our objective is to test an intervention designed to provide support during the survivorship transition for this population, who live with a high degree of morbidity related to the illness and its treatment as well as a high risk of recurrence. Study participants will be randomly assigned to receive survivorship care using the POSTCare-O process or usual care. The primary outcome is quality of life at 12 weeks after intervention.

Eligibility Criteria

Inclusion Criteria:Stage 2-4 ovarian cancerTreated with some combination of surgery, chemotherapy, biologics, maintenance therapyWithin 6 months of completion of initial treatment (continued maintenance therapy okay)Able to provide consent in English or SpanishExclusion Criteria:Admission to hospice at completion of treatment for ovary cancer

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05752448). StuddyBuddy aggregates publicly available trial information.